Display options
Cite
Cooper DK, Hara H, Ezzelarab M, et al. The potential of genetically-engineered pigs in providing an alternative source of organs and cells for transplantation. J Biomed Res. 2013;27(4):249-53doi: 10.7555/JBR.27.20130063.
Cooper, D. K., Hara, H., Ezzelarab, M., Bottino, R., Trucco, M., Phelps, C., Ayares, D., & Dai, Y. (2013). The potential of genetically-engineered pigs in providing an alternative source of organs and cells for transplantation. Journal of biomedical research, 27(4), 249-53. https://doi.org/10.7555/JBR.27.20130063
Cooper, David K C, et al. "The potential of genetically-engineered pigs in providing an alternative source of organs and cells for transplantation." Journal of biomedical research vol. 27,4 (2013): 249-53. doi: https://doi.org/10.7555/JBR.27.20130063
Cooper DK, Hara H, Ezzelarab M, Bottino R, Trucco M, Phelps C, Ayares D, Dai Y. The potential of genetically-engineered pigs in providing an alternative source of organs and cells for transplantation. J Biomed Res. 2013 Jul;27(4):249-53. doi: 10.7555/JBR.27.20130063. Epub 2013 Jun 12. PMID: 23885264; PMCID: PMC3721033.
Copy Download .nbib Format: NLM
Share it on

J Biomed Res. 2013 Jul;27(4):249-53. doi: 10.7555/JBR.27.20130063. Epub 2013 Jun 12.

The potential of genetically-engineered pigs in providing an alternative source of organs and cells for transplantation.

Journal of biomedical research

David K C Cooper, Hidetaka Hara, Mohamed Ezzelarab, Rita Bottino, Massimo Trucco, Carol Phelps, David Ayares, Yifan Dai

Affiliations

  1. Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA 15261, USA;

PMID: 23885264 PMCID: PMC3721033 DOI: 10.7555/JBR.27.20130063

Abstract

There is a critical shortage of organs, cells, and corneas from deceased human donors worldwide. There are also shortages of human blood for transfusion. A potential solution to all of these problems is the transplantation of organs, cells, and corneas from a readily available animal species, such as the pig, and the transfusion of red blood cells from pigs into humans. However, to achieve these ends, major immunologic and other barriers have to be overcome. Considerable progress has been made in this respect by the genetic modification of pigs to protect their tissues from the primate immune response and to correct several molecular incompatibilities that exist between pig and primate. These have included knockout of genes responsible for the expression of major antigenic targets for primate natural anti-pig antibodies, insertion of human complement- and coagulation-regulatory transgenes, and knockdown of swine leukocyte antigens that stimulate the primate's adaptive immune response. As a result of these manipulations, the administration of novel immunosuppressive agents, and other innovations, pig hearts have now functioned in baboons for 6-8 months, pig islets have maintained normoglycemia in diabetic monkeys for > 1 year, and pig corneas have maintained transparency for several months. Clinical trials of pig islet transplantation are already in progress. Future developments will involve further genetic manipulations of the organ-source pig, with most of the genes that are likely to be beneficial already identified.

Keywords: blood transfusion; genetic-engineered; islets; organs; pig; xenotransplantation

References

  1. Transplantation. 1998 Sep 15;66(5):547-61 - PubMed
  2. Xenotransplantation. 2009 Nov-Dec;16(6):477-85 - PubMed
  3. Xenotransplantation. 2013 Jan-Feb;20(1):27-35 - PubMed
  4. Invest Ophthalmol Vis Sci. 2011 Jul 15;52(8):5278-86 - PubMed
  5. Xenotransplantation. 2004 Sep;11(5):416-25 - PubMed
  6. J Heart Transplant. 1988 May-Jun;7(3):238-46 - PubMed
  7. Xenotransplantation. 2012 Sep-Oct;19(5):311-6 - PubMed
  8. Curr Opin Organ Transplant. 2011 Apr;16(2):190-4 - PubMed
  9. Cornea. 2011 Apr;30(4):371-8 - PubMed
  10. Immunology. 2011 Dec;134(4):386-97 - PubMed
  11. Lancet. 2012 Feb 18;379(9816):672-83 - PubMed
  12. Diabetes. 2012 Dec;61(12):3046-55 - PubMed
  13. J Heart Lung Transplant. 1991 Mar-Apr;10(2):223-34 - PubMed
  14. Science. 2003 Jan 17;299(5605):411-4 - PubMed
  15. Nat Med. 1995 Sep;1(9):964-6 - PubMed
  16. Xenotransplantation. 2011 Jan-Feb;18(1):1-5 - PubMed
  17. Transfusion. 2009 Nov;49(11):2418-29 - PubMed
  18. Xenotransplantation. 2012 May-Jun;19(3):144-58 - PubMed
  19. Immunology. 2013 Sep;140(1):39-46 - PubMed
  20. Curr Opin Organ Transplant. 2011 Apr;16(2):222-30 - PubMed
  21. Nat Biotechnol. 2002 Mar;20(3):251-5 - PubMed

Publication Types

Grant support